Page last updated: 2024-12-05
texanol
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
Texanol: a paint additive; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 6490 |
| CHEMBL ID | 3184970 |
| SCHEMBL ID | 56321 |
| MeSH ID | M0522465 |
Synonyms (46)
| Synonym |
|---|
| LS-14159 |
| 2,2,4-trimethyl-1,3-pentanediol monoisobutyrate |
| texanol |
| NCGC00164419-01 |
| 25265-77-4 |
| (3-hydroxy-2,2,4-trimethylpentyl) 2-methylpropanoate |
| 2,2,4-trimethyl-1,3-pentanediol 1-isobutyrate |
| 3-hydroxy-2,2,4-trimethylpentyl isobutyrate |
| I0405 |
| isobutyric acid 3-hydroxy-2,2,4-trimethylpentyl ester |
| NCGC00248541-01 |
| propanoic acid, 2-methyl-, 3-hydroxy-2,2,4-trimethylpentyl ester |
| 77-68-9 |
| 9lji14453c , |
| unii-9lji14453c |
| einecs 201-049-2 |
| 1,3-pentanediol, 2,2,4-trimethyl-, 1-isobutyrate |
| isobutyraldehyde trimer |
| tox21_200148 |
| cas-25265-77-4 |
| dsstox_rid_78592 |
| NCGC00257702-01 |
| dsstox_gsid_27857 |
| dsstox_cid_7857 |
| 2,2,4-trimethyl-1,3-pentanediolmono(2-methylpropanoate) |
| AKOS015900105 |
| isobutyric acid, 3-hydroxy-2,2,4-trimethylpentyl ester |
| 2,2,4-trimethyl-1,3-pentanediol 1-isobutyrate, (+/-)- |
| (+/-)-2,2,4-trimethyl-1,3-pentanediol 1-isobutyrate |
| SCHEMBL56321 |
| 3-hydroxy-2,2,4-trimethylpentyl 2-methylpropionate |
| component of texanol |
| 3-hydroxy-2,2,4-trimethylpentyl 2-methylpropanoate |
| CHEMBL3184970 |
| J-506772 |
| DTXSID10872295 |
| mfcd00148967 |
| 3-hydroxy-2,2,4-trimethylpentyl isobutyrate (contains ca. 40% 2,2,4-trimethyl-1,3-pentanediol 3-monoisobutyrate) |
| FT-0699920 |
| Q27272708 |
| texanolesteralcohol |
| 2-methyl-propanoic acid 3-hydroxy-2,2,4-trimethylpentyl ester |
| 3-hydroxy-2,2,4-trimethylpentylisobutyrate |
| CS-W014835 |
| 1185060-32-5 |
| isobutyric acid 2,2,4-trimethylpentane-1,3-diol ester |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Protein Targets (1)
Potency Measurements
| Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| thyroid hormone receptor beta isoform 2 | Rattus norvegicus (Norway rat) | Potency | 13.7272 | 0.0003 | 23.4451 | 159.6830 | AID743065 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
Research
Studies (7)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 55.30
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.
| This Compound (55.30) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 1 (14.29%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (85.71%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||